Keratoconus is a disease affecting the cornea where the cornea bows forward abnormally, causing blurred vision. It is a fairly common condition, affecting about 1 in 400 people. It tends to run in families, and there is a strong correlation with eye rubbing and ocular allergies. Children can sometimes be affected, and their vision can deteriorate very rapidly. It is particularly critical to treat children with keratoconus promptly once the diagnosis is made. You can learn more about keratoconus through the National Keratoconus Foundation’s excellent website https://www.nkcf.org/. In the past, the only treatments for keratoconus were hard contact lenses or a corneal transplant.
At Dell Laser Consultants, we have performed several FDA clinical trials for treating keratoconus (and a related condition called corneal ectasia) using a technique known as corneal collagen cross-linking. Corneal collagen cross-linking uses ultraviolet light and the vitamin riboflavin to strengthen the cornea and hopefully stop the progression of the disease. Dr. Dell was first surgeon in Austin to offer this technology and served the chairman of the first national meeting on corneal cross-linking in the US. After several years of clinical trials, we were delighted to see Corneal Collagen Cross-linking receive FDA approval in 2016.
If you or anyone you know has been diagnosed with keratoconus or corneal ectasia, we strongly encourage you to contact us for this revolutionary treatment. To help you better understand how Cross-Linking can help treat these common concerns, we have provided answers to a number of frequently asked questions about CXL.
If you have additional questions about Corneal Collagen Cross-Linking in Austin, or if you would like to schedule an appointment with one of our experienced eye doctors, please contact us today.
Frequently Asked Questions About Corneal Cross-Linking
Want to Learn More
Interested in Corneal Cross-Linking? Click the button below to contact us!